# Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

> **NCT01348412** · PHASE2 · COMPLETED · sponsor: **Centre Georges Francois Leclerc** · enrollment: 31 (actual)

## Conditions studied

- Colorectal Cancer
- Liver Metastases

## Interventions

- **DRUG:** oxaliplatin
- **DRUG:** raltitrexed
- **DRUG:** other intravenous chemotherapy drugs

## Key facts

- **NCT ID:** NCT01348412
- **Lead sponsor:** Centre Georges Francois Leclerc
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12-15
- **Primary completion:** 2010-12-15
- **Final completion:** 2018-04-18
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2018-07-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01348412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01348412, "Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01348412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*